Induction of virus-specific neutralizing immune response against West Nile and Japanese encephalitis viruses by chimeric peptides representing T-helper and B-cell epitopes

Virus Research

Volumn 163, Issue 1, 2012, Pages 40-50

  Gangwar, Roopesh Singh ^a   Shil, Pratip ^a   Sapkal, Gajanan N ^a   Khan, Siraj A ^b   Gore, Milind M ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

^b Regional Medical Research Centre   (India)

Author keywords

B cell epitopes; Chimeric peptides; Immunofluorescence assay; Japanese encephalitis virus; Peptide ELISA; Peptide vaccine; T helper epitopes; West Nile virus

Indexed keywords

E VIRUS PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BIOINFORMATICS; CONTROLLED STUDY; CROSS REACTION; CRYSTAL STRUCTURE; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREACTIVITY; IN VITRO STUDY; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; VIRUS INDUCTION; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUS, JAPANESE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; WEST NILE VIRUS;

JAPANESE ENCEPHALITIS VIRUS; JAPANESE ENCEPHALITIS VIRUS GROUP; MUS; WEST NILE VIRUS;

EID: 84855602220     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.08.008     Document Type: Article

References (102)

1. Anandarao R., Swaminathan S., Khanna N. The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides. Virus Res. 2005, 112(1-2):60-68.
2. Arnold K., Bordoli L., Kopp J., Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006, 22(2):195-201.
3. Beasley D.W., Barrett A.D. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J. Virol. 2002, 76(24):13097-13100.
4. Brinton M.A., Kurane I., Mathew A., Zeng L., Shi P.Y., Rothman A., Ennis F.A. Immune mediated and inherited defences against flaviviruses. Clin. Diagn. Virol. 1998, 10(2-3):129-139.
5. Brown H.E., Childs J.E., Diuk-Wasser M.A., Fish D. Ecological factors associated with West Nile virus transmission, northeastern United States. Emerg. Infect. Dis. 2008, 14(10):1539-1545.
6. Chen S.W., Van Regenmortel M.H., Pellequer J.L. Structure-activity relationships in peptide-antibody complexes: implications for epitope prediction and development of synthetic peptide vaccines. Curr. Med. Chem. 2009, 16(8):953-964.
7. Chowers M.Y., Green M.S., Bin H., Weinberger M., Schlaeffer F., Pitlik S., Bishara J., Kaufman Z., Dichtiar R., Mendelson E., Segev S. Post-epidemic serosurvey of West Nile fever in Israel. Eur. J. Clin. Microbiol. Infect. Dis. 2005, 24(12):851-853.
8. Chu J.H., Chiang C.C., Ng M.L. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. J. Immunol. 2007, 178(5):2699-2705.
9. Courtenay-Luck N.S., Epenetos A.A., Moore R., Larche M., Pectasides D., Dhokia B., Ritter M.A. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res. 1986, 46(12 Pt 1):6489-6493.
10. Cox J.H., Ivanyi J., Young D.B., Lamb J.R., Syred A.D., Francis M.J. Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur. J. Immunol. 1988, 18(12):2015-2019.
11. Dauphin G., Zientara S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine 2007, 25(30):5563-5576.
12. Davidson A.H., Traub-Dargatz J.L., Rodeheaver R.M., Ostlund E.N., Pedersen D.D., Moorhead R.G., Stricklin J.B., Dewell R.D., Roach S.D., Long R.E., Albers S.J., Callan R.J., Salman M.D. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J. Am. Vet. Med. Assoc. 2005, 226(2):240-245.
13. Denton G., Hudecz F., Kajtar J., Murray A., Tendler S.J., Price M.R. Sequential order of T and B cell epitopes affects immunogenicity but not antibody recognition of the B cell epitope. Pept. Res. 1994, 7(5):258-264.
14. Dewasthaly S., Ayachit V.M., Sarthi S.A., Gore M.M. Monoclonal antibody raised against envelope glycoprotein peptide neutralizes Japanese encephalitis virus. Arch. Virol. 2001, 146(7):1427-1435.
15. Dewasthaly S.S., Bhonde G.S., Shankarraman V., Biswas S.M., Ayachit V.M., Gore M.M. Chimeric T helper-B cell peptides induce protective response against Japanese encephalitis virus in mice. Protein Pept. Lett. 2007, 14(6):543-551.
16. Diagana M., Preux P.M., Dumas M. Japanese encephalitis revisited. J. Neurol. Sci. 2007, 262(1-2):165-170.
17. Fischer N.O., Infante E., Ishikawa T., Blanchette C.D., Bourne N., Hoeprich P.D., Mason P.W. Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis. Bioconjug. Chem. 2010, 21(6):1018-1022.
18. Gangwar R.S., Shil P., Cherian S.S., Gore M.M. Delineation of an epitope on domain I of Japanese Encephalitis Virus envelope glycoprotein using monoclonal antibodies. Virus Res. 2011, 158(1-2):179-187.
19. George S., Gourie-Devi M., Rao J.A., Prasad S.R., Pavri K.M. Isolation of West Nile virus from the brains of children who had died of encephalitis. Bull. World Health Organ. 1984, 62(6):879-882.
20. Gershoni-Yahalom O., Landes S., Kleiman-Shoval S., Ben-Nathan D., Kam M., Lachmi B.E., Khinich Y., Simanov M., Samina I., Eitan A., Cohen I.R., Rager-Zisman B., Porgador A. Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge. Immunology 2010, 130(4):527-535.
21. Geysen H.M., Barteling S.J., Meloen R.H. Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc. Natl. Acad. Sci. U.S.A. 1985, 82(1):178-182.
22. Gomara M.J., Girona V., Ercilla G., Reig F., Alsina M.A., Haro I. Differences in secondary structure of HAV-synthetic peptides induced by the sequential order of T- and B-cell epitopes. Biopolymers 2001, 58(2):117-128.
23. Gore M.M., Gupta A.K., Ayachit V.M., Athawale S.S., Ghosh S.N., Banerjee K. Selection of a neutralization-escape variant strain of Japanese encephalitis virus using monoclonal antibody. Indian J. Med. Res. 1990, 91:231-233.
24. Gould L.H., Fikrig E. West Nile virus: a growing concern?. J. Clin. Invest. 2004, 113(8):1102-1107.
25. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18(15):2714-2723.
26. Huang J.H., Wey J.J., Lee H.F., Tsou T.L., Wu C.S., Wu J.R., Chen H.M., Chin C., Chien L.J., Chen L.K., Wu Y.C., Pan M.J., Wang T.M. Identification of immunodominant, group-specific and subcomplex-specific, continuous epitopes in the core regions of Japanese encephalitis virus using synthetic peptides. Virus Res. 1996, 41(1):43-53.
27. Hubalek Z., Halouzka J. West Nile fever-a reemerging mosquito-borne viral disease in Europe. Emerg. Infect. Dis. 1999, 5(5):643-650.
28. Ilyas A.A., Chou D.K., Jungalwala F.B., Costello C., Quarles R.H. Variability in the structural requirements for binding of human monoclonal anti-myelin-associated glycoprotein immunoglobulin M antibodies and HNK-1 to sphingoglycolipid antigens. J. Neurochem. 1990, 55(2):594-601.
29. Iyer A.V., Pahar B., Boudreaux M.J., Wakamatsu N., Roy A.F., Chouljenko V.N., Baghian A., Apetrei C., Marx P.A., Kousoulas K.G. Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01. Vaccine 2009, 27(6):893-903.
30. Jemmerson R., Hutchinson R.M. Fine manipulation of antibody affinity for synthetic epitopes by altering peptide structure: antibody binding to looped peptides. Eur. J. Immunol. 1990, 20(3):579-585.
31. Kabilan L. A modified immunofluorescence assay for detection of Japanese encephalitis virus-infected cells. Acta Virol. 2001, 45(4):253-255.
32. Kabilan L., Vrati S., Ramesh S., Srinivasan S., Appaiahgari M.B., Arunachalam N., Thenmozhi V., Kumaravel S.M., Samuel P.P., Rajendran R. Japanese encephalitis virus (JEV) is an important cause of encephalitis among children in Cuddalore district, Tamil Nadu, India. J. Clin. Virol. 2004, 31(2):153-159.
33. Kanesa-thasan N., Smucny J.J., Hoke C.H., Marks D.H., Konishi E., Kurane I., Tang D.B., Vaughn D.W., Mason P.W., Shope R.E. Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus-poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine 2000, 19(4-5):483-491.
34. Katyal R., Bhardwaj M., Harit A., Sharma S., Kumar K., Gill K. Dengue, Japanese encephalitis and West Nile flaviviral infections detected during a dengue out-break in Sonepat District, Haryana State, India. Dengue Bull. 2000, 24:24-28.
35. Kaur H., Raghava G.P. Prediction of beta-turns in proteins from multiple alignment using neural network. Protein Sci. 2003, 12(3):627-634.
36. Kazanji M., Heraud J.M., Merien F., Pique C., de The G., Gessain A., Jacobson S. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus). J. Gen. Virol. 2006, 87(Pt 5):1331-1337.
37. Kedarnath N., Prasad S.R., Dandawate C.N., Koshy A.A., George S., Ghosh S.N. Isolation of Japanese encephalitis & West Nile viruses from peripheral blood of encephalitis patients. Indian J. Med. Res. 1984, 79:1-7.
38. Khan S.A., Dutta P., Chowdhury P., Borah J., Topno R., Mahanta J. Co-infection of arboviruses presenting as Acute Encephalitis Syndrome. J. Clin. Virol. 2011, 51(1):5-7.
39. Khan S.A., Dutta P., Khan A.M., Chowdhury P., Borah J., Doloi P., Mahanta J. West nile virus infection, Assam, India. Emerg. Infect. Dis. 2011, 17(5):947-948.
40. Kim S., Li L., McMurtrey C.P., Hildebrand W.H., Weidanz J.A., Gillanders W.E., Diamond M.S., Hansen T.H. Single-chain HLA-A2 MHC trimers that incorporate an immunodominant peptide elicit protective T cell immunity against lethal West Nile virus infection. J. Immunol. 2010, 184(8):4423-4430.
41. Kolaskar A.S., Tongaonkar P.C. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990, 276(1-2):172-174.
42. Krchnak V., Mach O., Maly A. Computer prediction of potential immunogenic determinants from protein amino acid sequence. Anal. Biochem. 1987, 165(1):200-207.
43. Kumar P., Sulochana P., Nirmala G., Haridattatreya M., Satchidanandam V. Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort. J. Gen. Virol. 2004, 85(Pt 5):1131-1143.
44. Kutubuddin M., Gore M.M., Banerjee K., Ghosh S.N., Kolaskar A.S. Analysis of computer-predicted antibody inducing epitope on Japanese encephalitis virus. Acta Virol. 1993, 37(6):417-428.
45. Kutubuddin M., Kolaskar A.S., Galande S., Gore M.M., Ghosh S.N., Banerjee K. Recognition of helper T cell epitopes in envelope (E) glycoprotein of Japanese encephalitis, west Nile and Dengue viruses. Mol. Immunol. 1991, 28(1-2):149-154.
46. Lanciotti R.S., Roehrig J.T., Deubel V., Smith J., Parker M., Steele K., Crise B., Volpe K.E., Crabtree M.B., Scherret J.H., Hall R.A., MacKenzie J.S., Cropp C.B., Panigrahy B., Ostlund E., Schmitt B., Malkinson M., Banet C., Weissman J., Komar N., Savage H.M., Stone W., McNamara T., Gubler D.J. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999, 286(5448):2333-2337.
47. Larsen M.V., Lelic A., Parsons R., Nielsen M., Hoof I., Lamberth K., Loeb M.B., Buus S., Bramson J., Lund O. Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL. PLoS One 2010, 5(9):e12697.
48. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK-a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 1993, 26:283-291.
49. Leclerc C., Deriaud E., Megret F., Briand J.P., Van Regenmortel M.H., Deubel V. Identification of helper T cell epitopes of dengue virus E-protein. Mol. Immunol. 1993, 30(7):613-625.
50. Lieberman M.M., Nerurkar V.R., Luo H., Cropp B., Carrion R., de la Garza M., Coller B.A., Clements D., Ogata S., Wong T., Martyak T., Weeks-Levy C. Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin. Vaccine Immunol. 2009, 16(9):1332-1337.
51. Marfin A.A., Gubler D.J. Japanese encephalitis: the need for a more effective vaccine. Lancet 2005, 366(9494):1335-1337.
52. Martina B.E., Koraka P., van den Doel P., van Amerongen G., Rimmelzwaan G.F., Osterhaus A.D. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine 2008, 26(2):153-157.
53. Mathews J.H., Allan J.E., Roehrig J.T., Brubaker J.R., Uren M.F., Hunt A.R. T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus. J. Virol. 1991, 65(10):5141-5148.
54. Maupetit J., Derreumaux P., Tuffery P. PEP-FOLD: an online resource for de novo peptide structure prediction. Nucleic Acids Res. 2009, 37(Web Server issue):W498-W503.
55. McMurtrey C.P., Lelic A., Piazza P., Chakrabarti A.K., Yablonsky E.J., Wahl A., Bardet W., Eckerd A., Cook R.L., Hess R., Buchli R., Loeb M., Rinaldo C.R., Bramson J., Hildebrand W.H. Epitope discovery in West Nile virus infection: identification and immune recognition of viral epitopes. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(8):2981-2986.
56. Milich D.R. Synthetic T and B cell recognition sites: implications for vaccine development. Adv. Immunol. 1989, 45:195-282.
57. Minke J.M., Audonnet J.C., Fischer L. Equine viral vaccines: the past, present and future. Vet. Res. 2004, 35(4):425-443.
58. Minke J.M., Siger L., Karaca K., Austgen L., Gordy P., Bowen R., Renshaw R.W., Loosmore S., Audonnet J.C., Nordgren B. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl. 2004, (18):221-230.
59. Misra U.K., Kalita J. Overview: Japanese encephalitis. Prog. Neurobiol. 2010, 91(2):108-120.
60. Moynihan J.S., Jones D.H., Farrar G.H., Howard C.R. A novel microencapsulated peptide vaccine against hepatitis B. Vaccine 2001, 19(23-24):3292-3300.
61. Ng T., Hathaway D., Jennings N., Champ D., Chiang Y.W., Chu H.J. Equine vaccine for West Nile virus. Dev. Biol. (Basel) 2003, 114:221-227.
62. Nybakken G.E., Nelson C.A., Chen B.R., Diamond M.S., Fremont D.H. Crystal structure of the West Nile virus envelope glycoprotein. J Virol. 2006, 80(23):11467-11474.
63. Obeid O.E., Stanley C.M., Steward M.W. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus. Virus Res. 1996, 42(1-2):173-180.
64. Otvos L., Thurin J., Kollat E., Urge L., Mantsch H.H., Hollosi M. Glycosylation of synthetic peptides breaks helices. Phosphorylation results in distorted structure. Int. J. Pept. Protein Res. 1991, 38(5):476-482.
65. Paramasivan R., Mishra A.C., Mourya D.T. West Nile virus: the Indian scenario. Indian J. Med. Res. 2003, 118:101-108.
66. Parida M., Dash P.K., Tripathi N.K., Ambuj, Sannarangaiah S., Saxena P., Agarwal S., Sahni A.K., Singh S.P., Rathi A.K., Bhargava R., Abhyankar A., Verma S.K., Rao P.V., Sekhar K. Japanese Encephalitis Outbreak, India, 2005. Emerg. Infect. Dis. 2006, 12(9):1427-1430.
67. Partidos C.D., Stanley C.M., Steward M.W. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins. J. Gen. Virol. 1991, 72(Pt 6):1293-1299.
68. Paul S.D., Murthy D.P., Das M. Isolation of West Nile virus from a human case of febrile illness. Indian J. Med. Res. 1970, 58(9):1177-1179.
69. Petersen L.R., Roehrig J.T. West Nile virus: a reemerging global pathogen. Emerg. Infect. Dis. 2001, 7(4):611-614.
70. Peterson E.M., Cheng X., Qu Z., de la Maza L.M. The effect of orientation within a chimeric peptide on the immunogenicity of Chlamydia trachomatis epitopes. Mol. Immunol. 1996, 33(4-5):335-339.
71. Phukan A.C., Borah P.K., Mahanta J. Japanese encephalitis in Assam, northeast India. Southeast Asian J. Trop. Med. Public Health 2004, 35(3):618-622.
72. Pierson T.C., Diamond M.S. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev. Mol. Med. 2008, 10:e12.
73. Pothipunya S., Patarapotikul J., Rojanasuphot S., Tharavanij S. Mapping of functional epitopes of Japanese encephalitis virus using monoclonal antibodies. Southeast Asian J. Trop. Med. Public Health 1993, 24(2):277-283.
74. Power U.F., Plotnicky-Gilquin H., Goetsch L., Champion T., Beck A., Haeuw J.F., Nguyen T.N., Bonnefoy J.Y., Corvaia N. Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G protein. Vaccine 2001, 19(17-19):2345-2351.
75. Ripoll D.R. Conformational study of a peptide epitope shows large preferences for beta-turn conformations. Int. J. Pept. Protein Res. 1992, 40(6):575-581.
76. Rodrigues F.M., Ghosh S.N., Banerjee K., Chatterjee A.K., Gupta N.P. A post-epidemic serological survey of humans in Bankura district, West Bengal, following the epidemic of Japanese encephalitis in 1973. Indian J. Med. Res. 1975, 63(10):1478-1485.
77. Roehrig J.T., Johnson A.J., Hunt A.R., Beaty B.J., Mathews J.H. Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J. Virol. 1992, 66(6):3385-3390.
78. Roehrig J.T., Risi P.A., Brubaker J.R., Hunt A.R., Beaty B.J., Trent D.W., Mathews J.H. T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology 1994, 198(1):31-38.
79. Roy A., Tandon R., Agarwal S.K., Banerjee G. Seroprevalence of Japanese encephalitis virus infection in Lucknow, Uttar Pradesh. Indian J. Med. Res. 2006, 124(2):211-212.
80. Saini M., Vrati S. A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge. J. Virol. 2003, 77(6):3487-3494.
81. Sapkal G.N., Wairagkar N.S., Ayachit V.M., Bondre V.P., Gore M.M. Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection. Am. J. Trop. Med. Hyg. 2007, 77(6):1139-1145.
82. Savage H.M., Ceianu C., Nicolescu G., Karabatsos N., Lanciotti R., Vladimirescu A., Laiv L., Ungureanu A., Romanca C., Tsai T.F. Entomologic and avian investigations of an epidemic of West Nile fever in Romania in 1996, with serologic and molecular characterization of a virus isolate from mosquitoes. Am. J. Trop. Med. Hyg. 1999, 61(4):600-611.
83. Scott W.R.P., Hünenberger P.H., Tironi I.G., Mark A.E., Billeter S.R., Fennen J., Torda A.E., Huber T., Krüger P., van Gunsteren W.F. The GROMOS biomolecular simulation program package. J. Phys. Chem. A 1999, 103(19):3596-3607.
84. Singh R., Rothman A.L., Potts J., Guirakhoo F., Ennis F.A., Green S. Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses. J. Infect. Dis. 2010, 202(2):223-233.
85. Smithburn K.C., Hughes T.P., Burke A.W., Paul J.H. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 1940, 20:471-492.
86. Soares M.R., Bisch P.M., Campos de Carvalho A.C., Valente A.P., Almeida F.C. Correlation between conformation and antibody binding: NMR structure of cross-reactive peptides from T. cruzi, human and L. braziliensis. FEBS Lett. 2004, 560(1-3):134-140.
87. Spohn G., Jennings G.T., Martina B.E., Keller I., Beck M., Pumpens P., Osterhaus A.D., Bachmann M.F. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice. Virol. J. 2010, 7:146.
88. Spragg J., Schroder E., Stewart J.M., Austen K.F., Haber E. Structural requirements for binding to antibody of sequence variants of bradykinin. Biochemistry 1967, 6(12):3933-3941.
89. Su H., Caldwell H.D. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein. J. Exp. Med. 1992, 175(1):227-235.
90. Takahashi H., Pool V., Tsai T.F., Chen R.T. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000, 18(26):2963-2969.
91. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24(8):1596-1599.
92. Tsai T.F., Popovici F., Cernescu C., Campbell G.L., Nedelcu N.I. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998, 352(9130):767-771.
93. Umrigar M.D., Pavri K.M. Comparative serological studies on Indian strains of West Nile virus isolated from different sources. Indian J. Med. Res. 1977, 65(5):603-612.
94. Van Durme J., Delgado J., Stricher F., Serrano L., Schymkowitz J., Rousseau F. A graphical interface for the FoldX forcefield. Bioinformatics 2011, 27(12):1711-1712.
95. Van Gessel Y., Klade C.S., Putnak R., Formica A., Krasaesub S., Spruth M., Cena B., Tungtaeng A., Gettayacamin M., Dewasthaly S. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO((R))) induced neutralizing antibody titers. Vaccine 2011, 29(35):5925-5931.
96. van Gunsteren W.F., Berendsen H.J.C. Groningen Molecular Simulation (GROMOS) Library Manual 1987, BIOMOS b.v., Groningen.
97. Van Regenmortel M.H.V. Synthetic peptide vaccines and the search for neutralization B cell epitopes. Open Vaccine J. 2009, 2:33-44.
98. Wang B., Hua R.H., Tian Z.J., Chen N.S., Zhao F.R., Liu T.Q., Wang Y.F., Tong G.Z. Identification of a virus-specific and conserved B-cell epitope on NS1 protein of Japanese encephalitis virus. Virus Res. 2009, 141(1):90-95.
99. Watts D.M., Tesh R.B., Siirin M., Rosa A.T., Newman P.C., Clements D.E., Ogata S., Coller B.A., Weeks-Levy C., Lieberman M.M. Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine 2007, 25(15):2913-2918.
100. Work T.H., Shah K.V. Serological diagnosis of Japanese B type encephalitis in North Arcot District of Madras State, India, with epidemiological notes. Indian J. Med. Res. 1956, 10:582-592.
101. Zargarova T.A., Zargarov A.A., Bolotina I.A., Beresten S.F., Favorova O.O. A peptide, containing the universal antigenic determinant of tryptophanyl-tRNA-synthetase. Bioorg. Khim. 1990, 16(9):1259-1267.
102. Zhang Q., Wang P., Kim Y., Haste-Andersen P., Beaver J., Bourne P.E., Bui H.H., Buus S., Frankild S., Greenbaum J., Lund O., Lundegaard C., Nielsen M., Ponomarenko J., Sette A., Zhu Z., Peters B. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 2008, 36(Web Server issue):W513-W518.